Karyopharm announces planned merger with Ayrmid amid Chapter 11 bankruptcy filing
The merger is not final and other companies will be able to bid for Karyopharm’s assets
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Veradermics announces phase 3 results for oral minoxidil for hair loss
If approved, it would be the only FDA-approved, oral, non-hormonal treatment for pattern hair loss in both male and female patients
Shionogi to acquire IntraBio in deal worth $2bn
The deal will expand Shionogi’s growing portfolio with IntraBio’s rare diseases capabilities
Karyopharm announces planned merger with Ayrmid amid Chapter 11 bankruptcy filing
The merger is not final and other companies will be able to bid for Karyopharm’s assets
Alexion and Aide Health launch app for people with rare diseases
More than 3.5 million people in the UK live with a rare condition
MAD World Summit 2026 secures official accreditation from The CPD Group
MAD World Summit takes place in London on 26 November at Convene, 155 Bishopsgate
Latest content
The future of science communication is already on social
We need to make scientific information easier to find and support more evidence-based voices online
Read More
Trust doesn’t travel through channels. It travels through people
Influence rarely happens in a single post. Trust is built through repeated, credible interactions over time
Read More
Winning takes more than innovation – it requires an ecosystem ready to adopt it
The science is moving fast, but the healthcare ecosystems meant to absorb its solutions aren’t keeping pace
Read More
Eli Lilly names Ilya Yuffa as executive vice president and president, Lilly Global Markets
Patrik Jonsson, executive vice president and president, Lilly International, will retire at the end of 2026
Read More
Intelligence
Using the power of social media to break down obstacles preventing improved patient engagement
Connecting with patients and HCPs through social media channels needs care and consistency
Read More
Who’s steering? Why pharma needs humans at the helm of AI
Understanding how AI decisions are made, who owns the outcomes and how accountability travels across partners and platforms
Read More
The impact of AI and digital health on chronic diseases
Over the past decades, advances in information technology have fundamentally transformed the management of chronic diseases, but what impact is this having on the pharma industry?
Read More
Regulatory complexity: the challenges of navigating the new normal
How functional service provider models are helping pharma adapt to regulatory uncertainty
Read More
From ambition to action: realising the true value of health
Why industry needs to engage earlier, explain value more clearly, understand service pressures and take shared responsibility for implementation
Read More
Strengthening engagement with HCPs needs deep understanding not digital bombardment
Closing the critical gap between HCPs’ need for information and the pharma industry’s ability to deliver relevant, tailored content
Read More
Blogs
Latest
Inizio appoints Oisín Ó Gógáin as Chief People Officer
November 3, 2026 | Inizio|Pharma, healthcare
Inizio has appointed Oisín Ó Gógáin as Chief People Officer.
Medscape Education Wins “Partner of Hope Award” for Scleroderma Advocacy
October 30, 2026 | Medscape Education|Food Fight 2026, National Scleroderma Foundation, rare disease
Medscape Education receives National Scleroderma Foundation’s Rocky Mountain Chapter’s “Partner of Hope Award” for empowering the patient voice and shortening the diagnostic journey. This recognition …
INmune Bio establishes global commercialization framework for Ebstrocel™ through strategic agreement with Uniphar
October 26, 2026 | Uniphar|Ebstrocel™, Expanded access, INmune Bio, Market Access, Uniphar
Initial focus on named-patient access in selected European and MENA markets, providing a capital-efficient foundation for broader commercialization
Redefining Pediatric Epilepsy Care: Why We Must Move Beyond Symptom Suppression
October 21, 2026 | Medscape Education|#WomenInMedicine #Pediatrics #EpilepsyWarrior #HearFromHer
For families navigating pediatric epilepsy, the condition dictates every moment of their lives. The constant, crippling “anticipatory anxiety” of when the next seizure might hit …
ANTHEM strengthens team with three appointments following Healthy Influence launch
October 19, 2026 | Resonant Group|
Healthcare communications consultancy welcomes new talent as it invests in its next phase of growth
How pharma companies can use AI to scale personalized engagement without increasing complexity
November 3, 2026 | Inizio|AI, Pharma, healthcare
AI is creating a world of opportunities for pharma companies to deliver more personalized HCP and patient engagement. But realizing the full potential of AI …
Creating the conditions for product launch success in a time of volatility
November 3, 2026 | Inizio|Pharma, Product Launch, healthcare
Volatility is reshaping the conditions for successful product launches. Market dynamics can shift quickly, assumptions can change, and teams are increasingly expected to make confident …
Navigating uncertainty in life sciences
November 3, 2026 | Inizio|Pharma, healthcare
The life sciences industry is changing fast. Advances in AI, increasingly complex science, shifting market dynamics and evolving patient needs are creating new challenges for …
Going private: what our year taught me about the patients pharma hasn’t yet spotted
October 26, 2026 | 11 London|
A thought piece on the rise of private healthcare, and why brands should help new kinds of patients and HCPs
What the Most Favored Nation (MFN) policy means for UK Pharma
October 20, 2026 | Amiculum|
By Jed Avissar and Manca Povsic